[ad_1] Novartis AG said Monday that a trial to evaluate prostate-cancer drug Pluvicto met its…
Tag:
Novartis AG ADR
-
-
[ad_1] Novartis AG NOVN, +0.47% NVS, +2.05% said Monday that a study on a drug…
-
[ad_1] Novartis AG said Thursday that Swiss competition-authority officers visited the company’s headquarters as part…
-
[ad_1] Novartis AG is planning to spin off its generics-and-biosimilars division Sandoz and list it…
- 1
- 2